ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells

A new research paper was published in Oncotarget’s Volume 15 on March 14, 2024, entitled, “ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.”

Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 11.10.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

October 12, 2023

Older Adults Should Get Another COVID Booster, CDC Advisors Say

Adults ages 65 and older should receive an additional dose of the 2023-2024 COVID-19 vaccine this spring, according to CDC’s Advisory Committee on Immunization Practices

February 29, 2024

Weighted lottery helps ensure equitable allocation of scarce COVID-19 medication

A program designed to ensure fairness and that people living in the most disadvantaged U.S. neighborhoods would be offered a scarce, potentially life-saving medication proved

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.